Although mesenchymal induction of epithelial growth and differentiation is well recognized in embryogenesis, the same principle has rarely been considered in studies on placental development. However, careful examination of placental membrane development across species shows a strong correlation between trophoblast (epithelial) growth and differentiation on the one hand, and the migration and development of mesenchymal tissues that make intimate contact with that trophoblast, on the other.
The basic principles of placental development in mammals, and the evidence for mesenchymal stimulation of trophoblast growth during the process, are summarized (Fig. 1) . The first differentiation event in mammalian development occurs at, or just before, the blastocyst stage of embryonic growth and involves the differentiation of the outermost layer of cells into an epithelial phenotype, the trophoblast (see 1 in Fig. 1 ). The remaining cells form the inner cell mass (ICM) which eventually becomes the embryo, whereas the trophoblast, along with ICMderived mesodermal and endodermal components, forms the placenta. Next, extra-embryonic endoderm differentiates and migrates from the ICM (see 2 in Fig. 1 ) to form the yolk sac; the combined endoderm and trophoblast layers are referred to as chorion. Mesoderm then migrates between the endoderm and trophoblast layers to form the tri-layered, vascularized yolk sac placental membrane (see 3 in Fig. 1 ) and the chorion envelops the embryo to form the amnion (see 4 and 5 in Fig. 1 ). This is the limit of placental development in most marsupials but in eutherian mammals there is considerable further development, involving formation of the chorioallantois. This arises through migration of allantoic mesoderm from the hind gut area of the embryo (see 4 in Fig. 1 ) and its subsequent fusion with the chorion (see 5 in Fig. 1 ). In many species, an endoderm layer migrates along with the mesoderm to give rise to an allantoic sac (as shown in Fig. 1 ), but in others, such as primates, the endoderm forms a rudimentary duct and there is no fluid filled sac. The blood vessels that form within the mesenchyme of the chorioallantois constitute the fetal vasculature of the placenta, the major arteries and veins of which leave and enter the fetus via the umbilicus.
Throughout the development of the placenta, the epithelial trophoblast remains as the outermost layer and it is this tissue that makes an ever increasing area of intimate contact with maternal tissues. To acheive this, it undergoes considerable proliferation and differentiation and it develops a bewildering array of phenotypes, including the ability to invade maternal tissues, while at the same time avoiding maternal immunological recognition and rejection. Trophoblast growth and differentiation occur at different rates and in many different ways among mammals and their interaction with the maternal endometrium has been shown to have a profound effect (Wooding and Flint 1994) . However, there is also an obvious fetal drive to placental membrane development and it is possible to relate each significant stage of trophoblast proliferation and differentiation to the migration of extra-embryonic endoderm and/or mesoderm in contact with that trophoblast. For example, the rapid growth and expansion of the trophoblast layer in most artiodactyla, especially the porcine and ruminant species, can be related to endoderm migration. Likewise, early or 'primary' syncytiotrophoblast formation in rodents and humans is allied to early endoderm and/or mesoderm migration (Gardner The major components of the mammalian placental membranes are an epithelial surface layer, the trophoblast, and a heavily vascularized mesenchyme, the allantoic mesenchyme. The trophoblast layer makes the most intimate contact with maternal tissues and it displays a wide range of unusual, often invasive, phenotypes. However, one common feature of trophoblast development in all species is a strong correlation between the proliferation and differentiation of this epithelial layer and its physical contact with developing allantoic mesenchyme. This suggests an epithelial-mesenchymal interaction involving paracrine signals from allantoic mesenchyme acting on adjacent trophoblast. The expression patterns of several growth factors and their receptors, including hepatocyte growth factor-scatter factor (HGF-SF) and its receptor, c-met, support the hypothesis. Furthermore, HGF-SF and c-met gene knockout studies in mice indicate that HGF-SF and c-met are both essential for placental development. HGF-SF, in addition to being a potent mitogen, causes scattering and morphogenic changes in cultured cells and is believed to be an important mediator of the induction of epithelial differentiation during embryogenesis. This review evaluates the importance of mesenchymal induction of trophoblast growth and differentiation in placental development and argues that HGF-SF is a crucial component of the mesenchymal stimulus.
1983). However, the most dramatic changes in growth and phenotype occur after allantoic mesenchyme makes contact with trophoblast to form the chorioallantois. This initiates proliferation and migration of labyrinthine trophoblast in the murine placenta, chorionic villi formation in the haemochorial placenta of primates and the formation of noninvasive chorionic villi within the epitheliochorial placenta of the pig and horse.
Growth factors and cytokines are the most likely mediators of the allantoic mesenchymal stimulus to trophoblast and this rapidly growing, heavily vascularized tissue is a rich source of such factors. For example, expression of insulin-like growth factor II (IGF-II) is extremely high in allantoic mesenchyme (Redline et al., 1993; Lennard et al., 1995) and the reduced size of IGF-II knockout mice has been partly attributed to reduced placental size (DeChiara et al., 1991) . The mitogenic action of , 1987) . 1. The outermost cells of the blastocyst differentiate to form trophoblast (blue), while the remainder form the inner cell mass (ICM) which becomes the embryo. 2. Extra-embryonic endoderm (red) migrates and, together with trophoblast, forms the chorion. 3. Extra-embryonic mesoderm (orange) migrates between the trophoblast and endoderm to form the tri-layered yolk sac placenta; this is the limit of placental development in most marsupials but is only temporary in eutherians. 4. The chorion expands around the embryo to form the amnion (complete in 5) and the allantois (endoderm, red; mesoderm, pink) migrates from the embryo. 5. Allantoic mesoderm fuses with chorion to form the chorioallantois. This forms the definitive placenta in all eutherian mammals and it involves considerable proliferation and differentiation of trophoblast (blue). Not all eutherian placentae have an allantoic cavity as shown here, but they all possess allantoic mesenchyme, the vessels of which form the fetal vasculature of the placenta. This mesenchymal tissue is always in contact with the trophoblast that makes the most intimate contact with maternal tissues. It is this trophoblast that proliferates and invades to the greatest extent and shows the widest range of phenotypes. However, it does not undergo these changes until allantoic mesoderm makes contact with it.
IGF-II in the fetus appears to be mediated via its interaction with the IGF-I (type 1) receptor, rather than the IGF-II receptor, although the placenta may possess a third, as yet unidentified receptor (Baker et al., 1993) . The expression of colony-stimulating factor 1 (CSF-1) is also high in allantoic mesenchyme (stroma) of the chorionic villi within the human placenta and its receptor, c-fms, is expressed in the trophoblast layer (Kanzaki et al., 1992) . Likewise, keratinocyte growth factor and its receptor show the same pattern of expression in the chorionic villi of rhesus monkeys (Izumi et al., 1996) . However, evidence is emerging that possibly the most important growth factor in terms of trophoblast growth within the chorioallantoic placenta is hepatocyte growth factor-scatter factor (HGF-SF).
Hepatocyte growth factor-scatter factor (HGF-SF)
HGF-SF was first described and partially characterized in 1984 as hepatocyte growth factor (HGF), owing to its ability to stimulate the proliferation of hepatocytes in vitro (Nakamura et al., 1984) and later, as scatter factor (SF) through its ability to make epithelial cells scatter in vitro (Stoker et al., 1987) . Seven years later, human HGF and SF were shown to be identical (Weidner et al., 1991) , hence the rather cumbersome name of hepatocyte growth factor-scatter factor. HGF-SF has now been shown to exert many additional actions on cells, including induction of morphogenesis, the stimulation of T-cell adhesion to endothelium and enhancement of neurone survival (Brinkmann et al., 1995; Zarnegar and Michalopoulos, 1995) . It has been postulated to play a crucial role in tissue regeneration following injury and this has stimulated a great deal of interest in the molecule and its mode of action.
HGF-SF is a heparin-binding protein that is secreted as a large, single-chain, inert precursor (pro-HGF-SF). It then undergoes proteolytic digestion to give rise to the active dimer, which consists of a 60 000 kDa α-subunit and a 30 000 kDa β-subunit, linked by a single disulfide bond. It is structurally related to plasminogen and other serine proteases but lacks enzyme activity due to several amino acid substitutions within the catalytic site of the serine-protease-like domain. The receptor for HGF-SF is the product of the proto-oncogene, c-met, and cells co-transfected with the growth factor and its receptor cause tumours in nude mice (Tsarfaty et al., 1994) . The intracellular domain of the β-subunit of the receptor has tyrosine kinase activity and transduces all the effects of HGF-SF.
Mesenchymal expression of HGF-SF
In nearly all tissues examined, both during development and in the adult, HGF-SF is expressed by mesenchymal tissues and c-met is expressed by adjacent epithelia. For example, in the liver, HGF-SF is expressed by nonparenchymal cells and c-met by hepatocytes (Hu et al., 1993) and in the developing mammary gland, fibroblasts express HGF-SF, whereas the luminal and myoepithelial cells express c-met (Niranjan et al., 1995) . Expression of HGF-SF by mesenchyme is also supported by the finding that both the mouse and human HGF-SF promoter sequences are active in mesenchymal, but not epithelial, cells (Plaschke-Schlutter et al., 1995) . Furthermore, expression patterns of HGF-SF and c-met in the mouse embryo (Sonnenberg et al., 1993) suggest a fundamental role in development. For example, in all the major organs, including the stomach, lung, vertebra and intestine, HGF-SF was expressed in the mesenchyme and c-met was expressed in the adjacent epithelium. This relationship provides evidence for a role for HGF-SF in the developmental induction of epithelial cell differentiation by mesenchyme and it is supported by experimental evidence in the developing kidney (Woolf et al., 1995) and rabbit limb bud (Takebayashi et al., 1995) and in the gene knockout studies described below.
Gene knockout experiments
Two separate gene targeting studies, aimed at eliminating HGF-SF expression in mice, were reported early in 1995 (Schmidt et al., 1995; Uehara et al., 1995) and in both, all of the homozygous mutant embryos died before birth. About 10% of the homozygous embryos were dead at day 13 of gestation and all were dead by days 17-18, demonstrating a fundamental role for HGF-SF in development. However, while Uehara et al. (1995) reported major placental failure, but no developmental abnormalities in their HGF-SF null embryos, Schmidt et al. (1995) showed evidence of liver deficiency in their embryos in addition to the placental defect. The discrepancy between the two studies was attributed to the stage at which the embryos were analysed; Uehara et al. (1995) analysed embryos at day 13.5, whereas Schmidt et al. (1995) examined embryos at day 14.5. However, the placental failure in both experiments was identical and appeared to be due to a complete lack of development of labyrinthine trophoblast. This type of trophoblast does not develop in rodents until allantoic mesenchyme makes contact with trophoblast to form the chorioallantois, and it is therefore a prime example of the mesenchymal stimulation of trophoblast growth and differentiation outlined above. Since HGF-SF is produced by mesenchyme, the absence of labyrinthine trophoblast in both studies was almost certainly caused by the lack of HGF-SF in the allantoic mesenchyme (see Fig. 2 , which shows a mouse conceptus at day 10.5 of gestation with its developing placenta and the area in which labyrinthine trophoblast would normally develop). Uehara et al. (1995) also showed that normal (wild-type) mouse allantoic mesenchyme produced HGF-SF activity when cultured in vitro and that mouse trophoblast cells cultured in vitro in serum-free medium responded to added recombinantderived human HGF-SF. These experiments clearly support the hypothesis that allantoic mesenchyme-derived HGF-SF stimulates trophoblast growth and development within the chorioallantoic placenta of the mouse. The conclusion is that the allantoic mesenchyme makes contact with the trophoblast and induces proliferation, differentiation or both processes via c-met.
The c-met gene was also interrupted in mice using homologous recombination and the resulting homozygous mutants were identical to the HGF-SF null mice (Bladt et al. 1995) . That is, the embryos died at the same stage of gestation, showed the same placental and liver defects and also exhibited a lack of specific skeletal muscle development, which was confirmed by re-examination of the HGF-SF knockout embryos. Thus, unlike many other ubiquitous growth factors and their receptors, HGF-SF and c-met appear to be essential for embryonic and placental development, at least in mice.
Placental expression of HGF-SF
Although the cDNA sequence for human HGF-SF was obtained originally from a placental cDNA library (Nakamura et al., 1989) , and was purified from human and rodent placental tissues (Hernandez et al., 1992; Jin et al., 1993) , there have been very few studies localizing sites of expression of HGF-SF in mammalian placentae. The first immunohistochemical study suggested that HGF-SF was present in the syncytiotrophoblast layer lining the chorionic villi of the human placenta (Wolf et al., 1991) . This was unexpected as it suggested epithelial expression of the growth factor. However, a more recent study of the human placenta, using both in situ hybridization and immunohistochemistry, showed HGF-SF expression in the allantoic mesenchyme (stroma) of the chorionic villi and its receptor in trophoblast, as might be expected (Saito et al., 1995) . These authors also showed that HGF-SF stimulated DNA synthesis in human cytotrophoblast cells cultured in serum-free medium.
The author's own study on the horse placenta also demonstrated HGF-SF in mesenchyme and c-met in trophoblast (Stewart et al., 1995) . The equine placenta is unusual in that the trophoblast cells of only a discrete annulate region of the placenta, the chorionic girdle, become binucleate and invasive, while the remaining trophoblast remains noninvasive (Allen and Moor, 1972) . The chorionic girdle develops through rapid multiplication of trophoblast cells overlying the point of abutment of the enlarging allantois and regressing yolk sac, and the most likely explanation for this localized area of trophoblast differentiation is a mitogenic stimulus from allantoic mesenchyme acting on trophoblast that is adjacent to, but not part of, the chorioallantoic membrane. All of the trophoblast in contact with allantoic mesenchyme responds to the stimulus, but only that area of trophoblast that becomes the chorionic girdle acquires an invasive phenotype because the chorion in this region is not fused to the allantois and therefore has a different phenotype and responds in a different way. Furthermore, in situ hybridization demonstrated mRNA encoding HGF-SF in allantoic mesenchyme and mRNA encoding c-met in the trophoblast, but with particularly high concentrations in the chorionic girdle (Stewart et al., 1995) . In addition, both recombinant-derived human and mouse HGF-SF are mitogenic to horse cytotrophoblast cells grown in serum-free medium (F. Stewart and E. Gherardi, unpublished). These results indicate an important role for HGF-SF in development of the horse placenta and provide a feasible explanation of chorionic girdle development.
Although in situ hybridization studies have not been carried out on mouse placental tissues, Uehara et al. (1995) have demonstrated that HGF-SF was produced by cultured mouse allantoic mesenchyme and that explants of mouse trophoblast proliferated in response to HGF-SF. It is therefore almost certain that, as with human and horse placental membranes, mouse allantoic mesenchyme expresses HGF-SF and the trophoblast layer expresses c-met. Thus, when these two tissues make intimate contact in mice, the HGF-SF stimulates proliferation, differentiation, or both processes, of the cytotrophoblast into a highly specialized labyrinthine trophoblast that is necessary for full placental development.
Conclusions
Mesenchymal-epithelial interactions are important in placental development, particularly during formation of the chorioallantoic placenta in all eutherian mammals. Allantoic mesenchyme is a rich source of growth factors and cytokines, and these appear to act in a paracrine fashion on adjacent trophoblast to induce proliferation and differentiation. Evidence is accumulating to suggest that HGF-SF is one of the crucial growth factors involved in this process. Fig. 2 . Schematic representation highlighting placental development of a mouse conceptus at day 10.5 of gestation. Early, primary trophoblast (spongiotrophoblast) invades the maternal endometrium to form the ectoplacental cone and then allantoic mesenchyme (pink) migrates towards it and fuses with chorion to form the chorioallantois. Labyrinthine trophoblast develops beneath the spongiotrophoblast layer, but only after allantoic mesenchyme has fused with the chorion, and is therefore in very close contact with the cytotrophoblast that gives rise to the labyrinthine trophoblast. Since labyrinthine trophoblast is absent in the placentae of the hepatocyte growth factor-scatter factor (HGF-SF) and c-met null mice, it would appear that HGF-SF from the allantoic mesenchyme and c-met expressed on trophoblast are both essential for normal placental development in mice.
